title: Immunogenicity risk management for commercial advantage.
authors.forename: Nikolai
authors.initials: N
authors.lastname: Schwabe
authors.forename: Victoria
authors.initials: V
authors.lastname: Lawson
mesh_terms: D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001688:Biological Products / Q000009:adverse effects*; D003132:Commerce; D004342:Drug Hypersensitivity; D012308:Risk Management / Q000191:economics; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
chemical_list: D001688:Biological Products